Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
- Forums
- ASX - By Stock
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets...
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.98 |
Change
-0.020(0.10%) |
Mkt cap ! $2.553B |
Open | High | Low | Value | Volume |
$20.05 | $20.28 | $19.82 | $5.032M | 251.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 364 | $19.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.98 | 292 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 364 | 19.960 |
1 | 26 | 19.860 |
2 | 1130 | 19.850 |
2 | 6838 | 19.840 |
3 | 1235 | 19.820 |
Price($) | Vol. | No. |
---|---|---|
20.010 | 7275 | 1 |
20.040 | 1130 | 2 |
20.050 | 1195 | 1 |
20.090 | 1195 | 1 |
20.130 | 1195 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |